TY - JOUR
T1 - Effect of Resveratrol on Pregnancy, Prenatal Complications and Pregnancy-Associated Structure Alterations
AU - Ramli, Iman
AU - Posadino, Anna Maria
AU - Giordo, Roberta
AU - Fenu, Grazia
AU - Fardoun, Manal
AU - Iratni, Rabah
AU - Eid, Ali H.
AU - Zayed, Hatem
AU - Pintus, Gianfranco
N1 - Funding Information:
This work has been made possible thanks to grants from Progetto Fondazione di Sardegna -bando 2022–2023 and FAR2020-Pintus.
Publisher Copyright:
© 2023 by the authors.
PY - 2023/2
Y1 - 2023/2
N2 - Adverse pregnancy outcomes are considered significant health risks for pregnant women and their offspring during pregnancy and throughout their lifespan. These outcomes lead to a perturbated in-utero environment that impacts critical phases of the fetus’s life and correlates to an increased risk of chronic pathological conditions, such as diabetes, obesity, and cardiovascular diseases, in both the mother’s and adult offspring’s life. The dietary intake of naturally occurring antioxidants promotes health benefits and disease prevention. In this regard, maternal dietary intake of polyphenolic antioxidants is linked to a reduced risk of maternal obesity and cardio-metabolic disorders, positively affecting both the fetus and offspring. In this work, we will gather and critically appraise the current literature highlighting the effect/s of the naturally occurring polyphenol antioxidant resveratrol on oxidative stress, inflammation, and other molecular and physiological phenomena associated with pregnancy and pregnancy conditions, such as gestational diabetes, preeclampsia, and preterm labor. The resveratrol impact on prenatal complications and pregnancy-associated structures, such as the fetus and placenta, will also be discussed. Finally, we will draw conclusions from the current knowledge and provide future perspectives on potentially exploiting resveratrol as a therapeutic tool in pregnancy-associated conditions.
AB - Adverse pregnancy outcomes are considered significant health risks for pregnant women and their offspring during pregnancy and throughout their lifespan. These outcomes lead to a perturbated in-utero environment that impacts critical phases of the fetus’s life and correlates to an increased risk of chronic pathological conditions, such as diabetes, obesity, and cardiovascular diseases, in both the mother’s and adult offspring’s life. The dietary intake of naturally occurring antioxidants promotes health benefits and disease prevention. In this regard, maternal dietary intake of polyphenolic antioxidants is linked to a reduced risk of maternal obesity and cardio-metabolic disorders, positively affecting both the fetus and offspring. In this work, we will gather and critically appraise the current literature highlighting the effect/s of the naturally occurring polyphenol antioxidant resveratrol on oxidative stress, inflammation, and other molecular and physiological phenomena associated with pregnancy and pregnancy conditions, such as gestational diabetes, preeclampsia, and preterm labor. The resveratrol impact on prenatal complications and pregnancy-associated structures, such as the fetus and placenta, will also be discussed. Finally, we will draw conclusions from the current knowledge and provide future perspectives on potentially exploiting resveratrol as a therapeutic tool in pregnancy-associated conditions.
KW - fetus
KW - gestational diabetes
KW - placenta
KW - pre-eclampsia
KW - pregnancy
KW - prenatal
KW - preterm
KW - resveratrol
UR - http://www.scopus.com/inward/record.url?scp=85149256986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149256986&partnerID=8YFLogxK
U2 - 10.3390/antiox12020341
DO - 10.3390/antiox12020341
M3 - Review article
AN - SCOPUS:85149256986
SN - 2076-3921
VL - 12
JO - Antioxidants
JF - Antioxidants
IS - 2
M1 - 341
ER -